Airway bypass stents for emphysema, algorithm to exclude precapillary pulmonary hypertension, and sildenafil for pulmonary hypertension in heart failure with preserved ejection fraction

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Department of Medicine, Temple University School of Medicine, 3401 N. Broad Street, Philadelphia, PA 19140, USA. matthew.lammi@tuhs.temple.edu

Comment

Matthew R Lammi et al. Am J Respir Crit Care Med. 2012.

. 2012 Jun 15;185(12):1323-4.

doi: 10.1164/rccm.201202-0235RR.

¹ Division of Pulmonary and Critical Care Medicine, Department of Medicine, Temple University School of Medicine, 3401 N. Broad Street, Philadelphia, PA 19140, USA. matthew.lammi@tuhs.temple.edu

No abstract available

Comment on

A noninvasive algorithm to exclude pre-capillary pulmonary hypertension.
Bonderman D, Wexberg P, Martischnig AM, Heinzl H, Lang MB, Sadushi R, Skoro-Sajer N, Lang IM. Bonderman D, et al. Eur Respir J. 2011 May;37(5):1096-103. doi: 10.1183/09031936.00089610. Epub 2010 Aug 6. Eur Respir J. 2011. PMID: 20693249
Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.
Guazzi M, Vicenzi M, Arena R, Guazzi MD. Guazzi M, et al. Circulation. 2011 Jul 12;124(2):164-74. doi: 10.1161/CIRCULATIONAHA.110.983866. Epub 2011 Jun 27. Circulation. 2011. PMID: 21709061 Clinical Trial.
Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial.
Shah PL, Slebos DJ, Cardoso PF, Cetti E, Voelker K, Levine B, Russell ME, Goldin J, Brown M, Cooper JD, Sybrecht GW; EASE trial study group. Shah PL, et al. Lancet. 2011 Sep 10;378(9795):997-1005. doi: 10.1016/S0140-6736(11)61050-7. Lancet. 2011. PMID: 21907863 Clinical Trial.